Guidance
Update information
October 2018: A correction was made to table 2. The treatment for Lyme carditis in children aged 9 to 12 who are haemodynamically unstable was changed to intravenous ceftriaxone, and the first alternative was changed to oral doxycycline. A footnote was also added on using clinical judgement to determine doses of doxycycline in children under 12 years with severe infections.
Minor changes since publication
October 2018: The weight limit for calculating doses of intravenous ceftriaxone in children under 12 was amended in table 2.
July 2018: A correction was made to table 2 for the duration of treatment for Lyme arthritis or acrodermatitis chronica atrophicans in children aged 9 to 12 with a severe infection. Maximum doses for intravenous ceftriaxone treatment in children under 12 were also added.
May 2018: The definition for the Jarisch–Herxheimer reaction was amended to clarify when the reaction can start.
ISBN: 978-1-4731-2919-1